Dynavax Technologies (DVAX) Inventory Turnover Ratio, from third quarter 2025 to third quarter 2024, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 
Dynavax Technologies Corporation  (NASDAQ: DVAX)
 

Dynavax Technologies Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Dynavax Technologies's inventory turnover ratio, the ratio that measures Dynavax Technologies's ability to manage its supply chain, sequentially decreased to 0.76 in the third quarter 2025, which does not come as a surprise, as the Dynavax Technologies continue to experience headwinds, which also impact its supply chain. Dynavax Technologies's average inventory processing period in the Sep 30 2025 quarter, has increased to 480 days, from 474 days, in the Jun 30 2025 quarter.

Within Healthcare sector 345 other companies have achieved higher inventory turnover ratio. While Inventory turnover ratio total ranking has improved so far during the III Quarter 2025, to 1176, from total ranking in the second quarter 2025 at 1497.

DVAX Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Dynavax Technologies Corporation Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

DVAX Inventory Turnover Ratio (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter		 (Mar 31 2025)
I. Quarter		 (Dec 31 2024)
IV. Quarter		 (Sep 30 2024)
III. Quarter
Y / Y Inventory Growth 17.44 % 21.17 % 20.38 % 31.46 % 26.29 %
Y / Y Cost of Sales Growth 10.08 % 17.1 % 25.56 % 54.33 % -1.1 %
Inventory Turnover Ratio (TTM) 0.76 0.77 0.78 0.77 0.75
DVAX's Total Ranking # 1176 # 1497 # 1314 # 725 # 1487
Average inventory processing period 481 475 470 474 490
Seq. Inventory Growth -3.17 % 1.73 % 6.21 % 12.26 % -0.1 %
Seq. Cost of Sales Growth 2.62 % 1.93 % 2.68 % 2.49 % 9.17 %




Inventory Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 105
Healthcare Sector # 346
Overall Market # 1176

Inventory Turnover Ratio Statistics
High Average Low
3.66 1.46 0.16
(Jun 30 2022)   (Jun 30 2020)



DVAX Company Profile >> Back to DVAX Efficiency Comparisons >> Compare DVAX Inventory Turnover Ratio to its Competitors

Financial Statements
Dynavax Technologies's Inventories $ 73 Millions Visit DVAX's Balance sheet
Dynavax Technologies's Cost of Revenues TTM $ 56 Millions Visit DVAX's Income Statement
What are DVAX's Sales? Visit DVAX's Sales by Segment

Other Inventory Turnover Ratios
Dynavax Technologies's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Major Pharmaceutical Preparations Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
DVAX's Inventory Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for DVAX's Competitors
Inventory Turnover Ratio for DVAX's Suppliers
Inventory Turnover Ratio for DVAX's Customers

You may also want to know
DVAX's Sales Growth Rates DVAX's Pe Price to earnings ratio DVAX's Receivables Turnover Ratio DVAX's Stock Quote
DVAX's Net Income Growth Rates DVAX's Ps Price to Sales ratio DVAX's Sales per Employee DVAX's Asset Turnover Ratio
DVAX's Net Margin DVAX's Pb Price to Book ratio DVAX's Financial Strength Ratios DVAX's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Sep 30 2025, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Sep 30 2025 Inventories at quarter ending Sep 30 2025
Apyx Medical Corp  2.09 $ 17.000  Millions$ 8  Millions
Standard Biotools Inc   2.05 $ 68.000  Millions$ 33  Millions
Amphastar Pharmaceuticals Inc   2.04 $ 366.270  Millions$ 179  Millions
Encision Inc   2.04 $ 2.984  Millions$ 1  Millions
Ultragenyx Pharmaceutical Inc   2.04 $ 96.549  Millions$ 47  Millions
Ardelyx inc   2.03 $ 46.952  Millions$ 23  Millions
Clearpoint Neuro Inc   2.02 $ 13.282  Millions$ 7  Millions
Organon and Co   2.01 $ 2,833.000  Millions$ 1,406  Millions
Nature s Sunshine Products inc   1.99 $ 130.141  Millions$ 65  Millions
Sunshine Biopharma Inc   1.99 $ 25.004  Millions$ 13  Millions
Intuitive Surgical Inc   1.99 $ 3,230.000  Millions$ 1,622  Millions
Eton Pharmaceuticals Inc   1.96 $ 34.000  Millions$ 17  Millions
Bausch and Lomb Corp  1.95 $ 2,012.000  Millions$ 1,031  Millions
Allurion Technologies Inc   1.94 $ 6.882  Millions$ 4  Millions
Ocular Therapeutix Inc   1.94 $ 6.210  Millions$ 3  Millions
Cytek Biosciences Inc   1.93 $ 91.735  Millions$ 48  Millions
Bioventus Inc   1.92 $ 181.570  Millions$ 95  Millions
Lensar Inc   1.91 $ 31.843  Millions$ 17  Millions
Dariohealth Corp   1.91 $ 9.000  Millions$ 5  Millions
Zomedica Corp   1.91 $ 10.298  Millions$ 5  Millions
Evofem Biosciences Inc   1.90 $ 3.537  Millions$ 2  Millions
Tenon Medical Inc   1.89 $ 1.539  Millions$ 1  Millions
Utah Medical Products Inc  1.87 $ 15.835  Millions$ 8  Millions
Tela Bio Inc   1.87 $ 23.000  Millions$ 12  Millions
Retractable Technologies Inc  1.87 $ 37.865  Millions$ 20  Millions
Safe Pro Group Inc   1.86 $ 0.676  Millions$ 0  Millions
Creative Medical Technology Holdings Inc   1.85 $ 0.002  Millions$ 0  Millions
Astrotech Corp  1.85 $ 0.658  Millions$ 0  Millions
Neuroone Medical Technologies Corp  1.84 $ 3.956  Millions$ 2  Millions
Aytu Biopharma Inc  1.83 $ 20.000  Millions$ 11  Millions

Date modified: 2026-08-29T17:19:47+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.